From: The effect of spironolactone on calcineurin inhibitor induced nephrotoxicity: a multicenter randomized, double-blind, clinical trial (the SPIREN trial)
Primary endpoint
Secondary endpoints
Chrome-EDTA clearance
24 h urinary protein excretion
Renal fibrosis (morphology)
Cardiovascular events
Biomarkers of fibrosis in tissue, blood and urine